Myriad Genetics, Inc.
Myriad Genetics, Inc. scores highest on Earnings (51) and lowest on Price (36). Its PosiPenta is 43.34 out of 100, around the middle of similar companies.
On the Penta Grid this week, Myriad Genetics, Inc. is Grid #429 of 837 in the Healthcare sector in United States, and Grid #2,563 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | 43.34 | 36 | 51 | 46 | 42 | 41 |
| Fulgent Genetics, Inc. | 57.44 | 45 | 41 | 64 | 73 | 64 |
| Evolent Health, Inc. | 43.25 | 35 | 49 | 60 | 24 | 49 |
| Shattuck Labs, Inc. | 49.85 | 24 | 41 | 71 | 64 | 49 |
| Aclaris Therapeutics, Inc. | 42.60 | 17 | 37 | 53 | 57 | 49 |
| Phathom Pharmaceuticals, Inc. | 49.53 | 0 | 66 | 30 | 95 | 58 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.37 |
| P/B ratio | 1.25 |
EEarnings
| Trailing EPS | ₹-111.76 |
| Forward EPS | ₹-55.75 |
NNitro
| Price | 376.97 |
| 52-week high | 805.08 |
| 52-week low | 259.52 |
| Fall from 52-week high | 53.2% |
TTorque
| Return on equity (ROE) | -32.54% |
| Debt-to-equity | 0.69 |
AAnchor
| Beta (price swings) | 1.64 |
| Market cap | ₹3,605 Cr |
| Insider holding | 4.01% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Myriad Genetics, Inc.'s PosiPenta score?
Myriad Genetics, Inc.'s PosiPenta is 43.34 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Myriad Genetics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Myriad Genetics, Inc. is Grid #429 of 837 in the Healthcare sector in United States, and Grid #2,563 of 4,000 in United States.
Which PosiPenta pillar is strongest for Myriad Genetics, Inc.?
Earnings (growth), with a score of 51 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Myriad Genetics, Inc.?
Price (valuation), with a score of 36 out of 100: weaker than most similar companies.
Has Myriad Genetics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.99 points, from 40.35 to 43.34.
PositoAI is for research and education only and is not investment advice.